Literature DB >> 8631775

Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.

C Bougeret1, T Delaunay, F Romero, P Jullien, H Sabe, H Hanafusa, R Benarous, S Fischer.   

Abstract

The COOH-terminal Src kinase (Csk) is responsible for the phosphorylation of the conserved, negative regulatory, carboxyl-terminal tyrosine of most of the Src family protein tyrosine kinases. Up to now, no stable binding of Csk to Src kinases has been detected. We therefore decided to analyze this interaction using two systems which allow detection of transient interaction. We produced and purified recombinant proteins in the glutathione S-transferase prokaryotic expression system. First, using real-time biospecific interaction analysis (BIAcore(TM)), we detected in vitro a specific interaction between Csk and one of its substrates Lck, a lymphocyte-specific member of the Src family. This interaction requires the autophosphorylation of Lck on tyrosine 394 (the phosphorylation of which is correlated with an increase of the kinase activity) and involves a functional Csk SH2 domain. Second, using the yeast two-hybrid system, we confirmed in vivo the physical interaction between Csk and Lck. Furthermore, in vitro we showed that autophosphorylation of Lck on tyrosine 394 enhances the phosphorylation of Lck by Csk on the negative regulatory site, tyrosine 505, suggesting that activated Lck serves preferentially as substrate for Csk. These findings might explain the mechanism(s) by which Csk interacts with most of Src kinases to down-regulate their kinase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631775     DOI: 10.1074/jbc.271.13.7465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase.

Authors:  F Romero; M C Multon; F Ramos-Morales; A Domínguez ; J A Bernal; J A Pintor-Toro; M Tortolero
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

2.  Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.

Authors:  F Scholle; R Longnecker; N Raab-Traub
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts.

Authors:  Dominik Filipp; Behrouz Moemeni; Alessandra Ferzoco; Kirishanthy Kathirkamathamby; Jenny Zhang; Ondrej Ballek; Dominique Davidson; André Veillette; Michael Julius
Journal:  J Biol Chem       Date:  2008-07-27       Impact factor: 5.157

4.  Toggle switches, pulses and oscillations are intrinsic properties of the Src activation/deactivation cycle.

Authors:  Nikolai P Kaimachnikov; Boris N Kholodenko
Journal:  FEBS J       Date:  2009-08       Impact factor: 5.542

5.  Expressed protein ligation: a general method for protein engineering.

Authors:  T W Muir; D Sondhi; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

6.  How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism.

Authors:  Jérémie Rossy; David J Williamson; Katharina Gaus
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

7.  Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.

Authors:  Jiatao Zhou; Zhihui Xiao; Yanli Zhan; Xuemei Qu; Sisi Mou; Chong Deng; Tianxiang Zhang; Xin Lan; Shengfeng Huang; Yingqiu Li
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

8.  Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation.

Authors:  Jennifer A Rohrs; Pin Wang; Stacey D Finley
Journal:  Cell Mol Bioeng       Date:  2016-04-26       Impact factor: 2.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.